Eszopiclone is used for inducing hypnotic or sedative effects in humans. It was first introduced by Waylis Therapeutics Llc in its drug Lunesta on Dec 15, 2004. 15 different companies have introduced drugs containing Eszopiclone.
Eszopiclone Patents
Given below is the list of patents protecting Eszopiclone, along
with the drug name that holds that patent and the company name owning that
drug.
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
Eszopiclone Generic API Manufacturers
Several generic applications have been filed for Eszopiclone. The first generic version for Eszopiclone was by Teva Pharmaceuticals Usa Inc and was approved on May 23, 2011. And the latest generic version is by Hetero Labs Ltd Unit V and was approved on Jan 4, 2024.
Given below is the list of companies who have filed for
Eszopiclone generic, along with the locations of their manufacturing plants worldwide.
1. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Eszopiclone. Given below are the
details of the strengths of this generic introduced by
Aurobindo Pharma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
3MG
tablet
Prescription
ORAL
AB
Sep 15, 2016
1MG
tablet
Prescription
ORAL
AB
Sep 15, 2016
2MG
tablet
Prescription
ORAL
AB
Sep 15, 2016
Manufacturing Plant Locations
New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
Country
City
Firm Name
India
Medchal
Aurobindo Pharma Ltd
Sangareddy
Aurobindo Pharma Limited
Polepally, Mahaboob Nagar
Aurobindo Pharma Limited
Bachupally
Aurobindo Pharma Limited
United States
East Windsor
Aurobindo Pharma USA Inc
2. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 3 different strengths of generic version for Eszopiclone. Given below are the
details of the strengths of this generic introduced by
Chartwell Rx.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
1MG
tablet
Discontinued
ORAL
N/A
Jul 14, 2011
3MG
tablet
Discontinued
ORAL
N/A
Jul 14, 2011
2MG
tablet
Discontinued
ORAL
N/A
Jul 14, 2011
3. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 3 different strengths of generic version for Eszopiclone. Given below are the
details of the strengths of this generic introduced by
Dr Reddys.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
3MG
tablet
Prescription
ORAL
AB
Apr 15, 2014
1MG
tablet
Prescription
ORAL
AB
Apr 15, 2014
2MG
tablet
Prescription
ORAL
AB
Apr 15, 2014
4. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Eszopiclone. Given below are the
details of the strengths of this generic introduced by
Glenmark Pharms Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
1MG
tablet
Prescription
ORAL
AB
Apr 15, 2014
2MG
tablet
Prescription
ORAL
AB
Apr 15, 2014
3MG
tablet
Prescription
ORAL
AB
Apr 15, 2014
5. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 3 different strengths of generic version for Eszopiclone. Given below are the
details of the strengths of this generic introduced by
Hetero Labs Ltd V.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
1MG
tablet
Prescription
ORAL
AB
Jan 4, 2024
3MG
tablet
Prescription
ORAL
AB
Jan 4, 2024
2MG
tablet
Prescription
ORAL
AB
Jan 4, 2024
6. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Eszopiclone. Given below are the
details of the strengths of this generic introduced by
Hikma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
1MG
tablet
Discontinued
ORAL
N/A
Apr 15, 2014
2MG
tablet
Discontinued
ORAL
N/A
Apr 15, 2014
3MG
tablet
Discontinued
ORAL
N/A
Apr 15, 2014
Manufacturing Plant Locations
New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
Country
City
Firm Name
United States
Eatontown
Hikma Pharmaceuticals USA, Inc.
Cherry Hill
Hikma Pharmaceuticals USA Inc.
Dayton
Hikma Injectables USA Inc
Carlsbad
Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt
Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman
Hikma Pharmaceuticals LLC
7. IPCA LABS LTD
Ipca Laboratories Ltd has filed for 3 different strengths of generic version for Eszopiclone. Given below are the
details of the strengths of this generic introduced by
Ipca Labs Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
2MG
tablet
Prescription
ORAL
AB
Dec 29, 2023
1MG
tablet
Prescription
ORAL
AB
Dec 29, 2023
3MG
tablet
Prescription
ORAL
AB
Dec 29, 2023
8. LUPIN LTD
Lupin Ltd has filed for 3 different strengths of generic version for Eszopiclone. Given below are the
details of the strengths of this generic introduced by
Lupin Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
1MG
tablet
Prescription
ORAL
AB
Sep 13, 2011
2MG
tablet
Prescription
ORAL
AB
Sep 13, 2011
3MG
tablet
Prescription
ORAL
AB
Sep 13, 2011
Manufacturing Plant Locations
New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
Country
City
Firm Name
India
Aurangabad
Lupin Ltd.
9. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Eszopiclone. Given below are the
details of the strengths of this generic introduced by
Macleods Pharms Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
1MG
tablet
Prescription
ORAL
AB
Jan 30, 2015
2MG
tablet
Prescription
ORAL
AB
Jan 30, 2015
3MG
tablet
Prescription
ORAL
AB
Jan 30, 2015
10. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Eszopiclone. Given below are the
details of the strengths of this generic introduced by
Mylan Pharms Inc.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
1MG
tablet
Prescription
ORAL
AB
Mar 26, 2013
2MG
tablet
Prescription
ORAL
AB
Mar 26, 2013
3MG
tablet
Prescription
ORAL
AB
Mar 26, 2013
11. NOSTRUM LABS INC
Nostrum Laboratories Inc has filed for 3 different strengths of generic version for Eszopiclone. Given below are the
details of the strengths of this generic introduced by
Nostrum Labs Inc.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
3MG
tablet
Discontinued
ORAL
N/A
May 8, 2019
1MG
tablet
Discontinued
ORAL
N/A
May 8, 2019
2MG
tablet
Discontinued
ORAL
N/A
May 8, 2019
12. ORBION PHARMS
Orbion Pharmaceuticals Private Ltd has filed for 3 different strengths of generic version for Eszopiclone. Given below are the
details of the strengths of this generic introduced by
Orbion Pharms.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
3MG
tablet
Prescription
ORAL
AB
Jun 10, 2014
2MG
tablet
Prescription
ORAL
AB
Jun 10, 2014
1MG
tablet
Prescription
ORAL
AB
Jun 10, 2014
13. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Eszopiclone. Given below are the
details of the strengths of this generic introduced by
Sun Pharm.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
1MG
tablet
Prescription
ORAL
AB
Apr 3, 2013
3MG
tablet
Prescription
ORAL
AB
Apr 3, 2013
2MG
tablet
Prescription
ORAL
AB
Apr 3, 2013
Manufacturing Plant Locations
New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
Country
City
Firm Name
United States
Lexington
Sun Pharmaceutical Industries Inc
Billerica
Sun Pharmaceutical Industries, Inc.
Princeton
SUN PHARMACEUTICAL INDUSTRIES INC
India
Halol
Sun Pharmaceutical Industries Ltd.
New Delhi
Sun Pharmaceutical Industries Limited
Punjab
Sun Pharmaceutical Industries, Inc.
Ahmednagar
Sun Pharmaceutical Industries Limited
Malanpur, Bhind (District)
Sun Pharmaceutical Industries Limited
Vadodara
Sun Pharmaceutical Industries Ltd
Gurugram
Sun Pharmaceutical Industries Limited (prev. Ranbaxy)
Mohali
Sun Pharmaceutical Industries Limited
Kanchipuram
Sun Pharmaceutical Industries Limited- Madhuranthagam
Baruch
Sun Pharmaceutical Industries Ltd.
Vadodara
Sun Pharmaceutical Industries Ltd.
Vadodara
Sun Pharmaceutical Industries Limited - Karkhadi
Dadra
Sun Pharmaceutical Industries Limited
Bharuch
Sun Pharmaceutical Industries Ltd
14. TEVA
Teva Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Eszopiclone. Given below are the
details of the strengths of this generic introduced by
Teva.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
3MG
tablet
Prescription
ORAL
AB
May 23, 2011
2MG
tablet
Prescription
ORAL
AB
May 23, 2011
1MG
tablet
Prescription
ORAL
AB
May 23, 2011
Manufacturing Plant Locations
New
Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.
